Factors responsible for the differential procoagulant effects of diverse plasminogen activators in plasma
- 31 October 1991
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 5 (4) , 217-224
- https://doi.org/10.1016/0268-9499(91)90003-m
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1990
- Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator.Circulation, 1989
- Activation/inactivation of human factor V by plasminBlood, 1989
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA)Thrombosis Research, 1988
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1988
- Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysisJournal of the American College of Cardiology, 1987
- Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysisJournal of the American College of Cardiology, 1986
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974